Literature DB >> 28332089

Surgery for total anomalous pulmonary venous connection: primary sutureless repair vs. conventional repair.

Naoki Yoshimura1, Kazuaki Fukahara2, Akio Yamashita2, Toshio Doi2, Katsunori Takeuchi2, Shigeyuki Yamashita2, Takahiro Homma2, Shigeki Yokoyama2, Masaya Aoki2, Yuki Ikeno2.   

Abstract

Despite recent advances in surgical technique and perioperative care, the surgical correction of total anomalous pulmonary venous connection (TAPVC) remains a challenge. The major complication and the main cause of reoperation in TAPVC surgery are the occurrence of pulmonary venous obstruction (PVO). In the 1990s, sutureless repair was introduced as a technique to relieve PVO after TAPVC repair. Following the favorable outcomes for postoperative PVO, the indications for sutureless repair as a primary operation have been expanded to include infants who have preoperative PVO or those at risk of developing PVO after the repair of TAPVC. However, the indications of "prophylactic" primary sutureless repair still remain controversial. Recent studies have shown that normal-risk patients have excellent early and long-term outcomes and a low incidence of reoperation for postoperative PVO. Most patients who survived beyond 2 years after TAPVC surgery were in NYHA class I and offered good outcomes. Although favorable early and mid-term outcomes of primary sutureless repair are reported, the long-term outcomes of this technique are still unclear. The influence of non-contractile pericardial tissue interposed between the PV vessel wall and LA myocardium on the atrial function is also unclear in patients who undergo sutureless repair. Another disadvantage of primary sutureless repair is potential bleeding from the gap between the confluence and pericardium into the posterior mediastinum or pleural cavity. Thus, it might be best for primary sutureless repair to be indicated for high-risk infants, such as those with TAPVC associated with single-ventricular physiology, mixed-type TAPVC, or small PV confluence.

Entities:  

Keywords:  Pulmonary venous obstruction; Sutureless repair; Total anomalous pulmonary venous connection

Mesh:

Year:  2017        PMID: 28332089     DOI: 10.1007/s11748-017-0769-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  30 in total

Review 1.  Surgery for pulmonary venous obstruction after repair of total anomalous pulmonary venous return.

Authors:  François Lacour-Gayet
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2006

2.  Pulmonary vein stenosis following repair of total anomalous pulmonary venous connection.

Authors:  Eric J Devaney; Richard G Ohye; Edward L Bove
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2006

3.  The surgical treatment of transposition of the pulmonary veins.

Authors:  W H MULLER
Journal:  Ann Surg       Date:  1951-10       Impact factor: 12.969

Review 4.  Current topics in surgery for isolated total anomalous pulmonary venous connection.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Tatsuro Matsuo; Saori Nagura; Masaya Aoki; Kimimasa Sakata; Hayato Obi
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

5.  Total anomalous pulmonary venous connection: results of surgical repair of 100 patients at a single institution.

Authors:  Angela M Kelle; Carl L Backer; Jeffrey G Gossett; Sunjay Kaushal; Constantine Mavroudis
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-14       Impact factor: 5.209

6.  Primary sutureless repair for infants with mixed total anomalous pulmonary venous drainage.

Authors:  Osami Honjo; Cori R Atlin; Barbara C S Hamilton; Osman Al-Radi; Nicola Viola; John G Coles; Glen S Van Arsdell; Christopher A Caldarone
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

7.  Modified T-shaped left atrium incision in the bi-atrial approach for infracardiac type TAPVR repair.

Authors:  Chung-Dann Kan; Yu-Jen Yang
Journal:  Ann Thorac Surg       Date:  2011-06       Impact factor: 4.330

8.  Outcomes of surgery for simple total anomalous pulmonary venous drainage in neonates.

Authors:  Matthew S Yong; Yves d'Udekem; Terry Robertson; Stephen Horton; Mithilesh Dronavalli; Christian Brizard; Robert Weintraub; Frank Shann; Michael Cheung; Igor E Konstantinov
Journal:  Ann Thorac Surg       Date:  2011-03-24       Impact factor: 4.330

9.  Pulmonary vein and atrial wall pathology in human total anomalous pulmonary venous connection.

Authors:  Yvonne L Douglas; Monique R M Jongbloed; Wietske C E den Hartog; Margot M Bartelings; Ad J J C Bogers; Tjark Ebels; Marco C DeRuiter; Adriana C Gittenberger-de Groot
Journal:  Int J Cardiol       Date:  2008-12-30       Impact factor: 4.164

10.  Repair of "simple" total anomalous pulmonary venous connection: a review from the Pediatric Cardiac Care Consortium.

Authors:  James D St Louis; Brian A Harvey; Jeremiah S Menk; Geetha Raghuveer; James E O'Brien; Roosevelt Bryant; Lazaros Kochilas
Journal:  Ann Thorac Surg       Date:  2012-05-04       Impact factor: 4.330

View more
  3 in total

1.  Surgical Outcomes of Total Anomalous Pulmonary Venous Connection Repair.

Authors:  Radoslaw Jaworski; Andrzej Kansy; Joanna Friedman-Gruszczynska; Katarzyna Bieganowska; Malgorzata Mirkowicz-Malek
Journal:  Medicina (Kaunas)       Date:  2022-05-23       Impact factor: 2.948

Review 2.  Sutureless technique versus conventional surgery in the primary treatment of total anomalous pulmonary venous connection: a systematic review and meta-analysis.

Authors:  Yuhao Wu; Zhichao Wu; Junmeng Zheng; Yonggang Li; Yuehang Zhou; Hongyu Kuang; Xin Jin; Chun Wu
Journal:  J Cardiothorac Surg       Date:  2018-06-15       Impact factor: 1.637

3.  Numerical Simulation of Hemodynamics in Two Models for Total Anomalous Pulmonary Venous Connection Surgery.

Authors:  Yeyang Cheng; Aike Qiao; Yao Yang; Xiangming Fan
Journal:  Front Physiol       Date:  2020-03-10       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.